| Identification | |
| Name: | Hydroxymethyl Dasatinib |
| Synonyms: | Hydroxymethyl Dasatinib;N-[2-Chloro-6-(hydroxymethyl)phenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide |
| CAS: | 910297-58-4 |
| Molecular Formula: | C22H26ClN7O3S |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C22H26ClN7O3S/c1-14-25-18(11-19(26-14)30-7-5-29(6-8-30)9-10-31)27-22-24-12-17(34-22)21(33)28-20-15(13-32)3-2-4-16(20)23/h2-4,11-12,31-32H,5-10,13H2,1H3,(H,28,33)(H,24,25,26,27) |
| Molecular Structure: | ![(C22H26ClN7O3S) Hydroxymethyl Dasatinib;N-[2-Chloro-6-(hydroxymethyl)phenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl...](https://img.guidechem.com/structure/910297-58-4.gif) |
| Properties | |
| Density: | 1.465g/cm3 |
| Refractive index: | 1.705 |
| Usage: | An oxidative metabolite of Dasatinib (M24 metabolite); used in the treatment of cancers and immune diseases. |
| Safety Data | |
 |
|
